The Genetics and Subtypes of Huntington-Like Syndromes
At a Glance
Huntington disease-like (HDL) syndromes cause symptoms identical to Huntington's disease but are triggered by different genetic mutations. Because specific mutations cluster geographically, your ancestry provides crucial clues for doctors trying to identify the exact gene responsible.
When a patient shows the classic signs of Huntington’s Disease—involuntary movements, cognitive changes, and mood shifts—but tests negative for the HTT gene mutation, they are said to have a phenocopy [1].
A phenocopy is a medical “look-alike.” It is a condition that mimics the outward appearance of another disease but is caused by an entirely different genetic “instruction” [2][1]. In the case of Huntington Disease-Like (HDL) syndromes, your ancestry and family history are the most important clues doctors use to find the specific genetic cause. Discovering the precise genetic cause is crucial, not just for your treatment plan, but because it has immediate implications for the risks to your biological children and siblings.
How Your Ancestry Points to the Cause
Genetics are often tied to geography. Because certain mutations first appeared in specific populations, your ethnic background can make some HDL subtypes much more likely than others.
African Ancestry: HDL2
Huntington Disease-Like 2 (HDL2) is the most common mimic found in people of African descent [2]. It is caused by a repeat expansion in a gene called JPH3 [3]. Clinically, it is almost impossible to tell apart from classic HD without a genetic test [3].
European Ancestry: C9orf72
In people of European descent, the most frequent cause of an HD phenocopy is an expansion in the C9orf72 gene [4]. While this mutation is more famous for causing ALS (Lou Gehrig’s disease) or Frontotemporal Dementia, it can also present with the involuntary movements (chorea) typical of Huntington’s [5][6].
Asian Ancestry: SCA17 (HDL4)
Spinocerebellar Ataxia Type 17 (SCA17), also known as HDL4, is caused by a mutation in the TBP gene [7]. While it occurs globally, it has a notable presence in East Asian populations, including Chinese, Korean, and Japanese families [8]. It often includes ataxia—a specific type of clumsiness or “drunken” walk [9].
Rare and Global Subtypes
Some syndromes are “ultra-rare” and do not seem to cluster in any specific ethnic group.
- HDL1: Caused by a mutation in the PRNP gene (the prion protein gene) [10]. It is extremely rare and can progress much faster than classic HD [10].
- Neuroacanthocytosis (ChAc and McLeod): These syndromes involve misshapen red blood cells (“acanthocytes”) and are caused by mutations in the VPS13A or XK genes [11]. They are found globally and often involve unique symptoms like seizures or involuntary tongue biting [11][12].
Comparing the Genetic “Blueprints”
Understanding the biology helps explain why these diseases look so similar. Most involve “repeat expansions”—places where a tiny piece of the genetic code stutters and repeats itself too many times, eventually creating a protein that is toxic to brain cells [13].
It is incredibly important to understand the inheritance pattern of your specific syndrome.
- Dominant inheritance means you only need one copy of the mutated gene to develop the disease, giving your children a 50% chance of inheriting it.
- Recessive inheritance means you must inherit two copies (one from each parent) to get the disease. If you have a recessive syndrome, your children will only inherit the disease if your partner is also a carrier (which gives a 25% chance of a child having the disease).
| Subtype | Gene Involved | Mutation Type | Inheritance |
|---|---|---|---|
| HDL1 | PRNP | Insertion (an extra piece of DNA is added) | Dominant (50% chance for children) |
| HDL2 | JPH3 | Repeat Expansion | Dominant (50% chance for children) |
| SCA17 | TBP | Repeat Expansion | Dominant (50% chance for children) |
| C9orf72 | C9orf72 | Repeat Expansion | Dominant (50% chance for children) |
| ChAc | VPS13A | Various mutations | Recessive (25% chance, if partner is a carrier) |
| McLeod | XK | Various mutations | X-linked (mostly affects men; women are typically carriers) |
Note: HDL3 was a term once used for a single family in 2001, but a specific gene was never found, and it is no longer a standard diagnosis [10].
Common questions in this guide
What is a Huntington's disease phenocopy?
Why does ancestry matter for diagnosing Huntington-like syndromes?
What causes Huntington disease-like 2 (HDL2)?
Can a C9orf72 mutation look like Huntington's disease?
Will my children inherit a Huntington-like syndrome?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Based on my ancestry, which genetic tests for HDL syndromes should we prioritize?
- 2.Could you explain how my negative HTT test result changes our diagnostic plan?
- 3.Are there specific physical signs, like lip biting or balance issues, that might suggest one subtype over another?
- 4.Given that some of these syndromes are recessive, do you recommend testing my siblings or other family members?
- 5.How common are C9orf72 expansions in people with symptoms like mine who test negative for Huntington’s?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (13)
- 1
Huntington's Disease, Huntington's Disease Look-Alikes, and Benign Hereditary Chorea: What's New?
Schneider SA, Bird T
Movement disorders clinical practice 2016; (3(4)):342-354 doi:10.1002/mdc3.12312.
PMID: 30713928 - 2
Teaching Video NeuroImage: Peculiar Hobby Horse Gait in Huntington Disease-like 2.
Guimarães TG, Parmera JB, Barbosa ER, et al.
Neurology 2022; (98(24)):1031-1032 doi:10.1212/WNL.0000000000200603.
PMID: 35387851 - 3
A case of Huntington disease-like 2 in a patient of African ancestry: the everlasting support of clinical examination in the molecular era.
Ruscitti F, Origone P, Rosti G, et al.
Clinical case reports 2022; (10(10)):e6308 doi:10.1002/ccr3.6308.
PMID: 36237940 - 4
Knock in of a hexanucleotide repeat expansion in the C9orf72 gene induces ALS in rats.
Dong W, Zhang L, Sun C, et al.
Animal models and experimental medicine 2020; (3(3)):237-244 doi:10.1002/ame2.12129.
PMID: 33024945 - 5
Screening for the C9ORF72 expansion in Greek Huntington Disease phenocopies and controls and meta-analysis of current data.
Rikos D, Marogianni C, Provatas A, et al.
Tremor and other hyperkinetic movements (New York, N.Y.) 2020; (10()):5 doi:10.5334/tohm.61.
PMID: 32775019 - 6
Disease Mechanisms and Therapeutic Approaches in C9orf72 ALS-FTD.
Mayl K, Shaw CE, Lee YB
Biomedicines 2021; (9(6)) doi:10.3390/biomedicines9060601.
PMID: 34070550 - 7
Generation of induced pluripotent stem cell line RCPCMi008-A derived from patient with spinocerebellar ataxia 17.
Shuvalova LD, Davidenko AV, Eremeev AV, et al.
Stem cell research 2021; (54()):102431 doi:10.1016/j.scr.2021.102431.
PMID: 34171784 - 8
Mutation analysis of the TATA box-binding protein (TBP) gene in Russian patients with spinocerebellar ataxia and Huntington disease-like phenotype.
Ivanova E, Nuzhnyi E, Abramycheva N, et al.
Clinical neurology and neurosurgery 2022; (222()):107473 doi:10.1016/j.clineuro.2022.107473.
PMID: 36252335 - 9
Spinocerebellar Ataxia Type 17 (SCA17).
Toyoshima Y, Takahashi H
Advances in experimental medicine and biology 2018; (1049()):219-231 doi:10.1007/978-3-319-71779-1_10.
PMID: 29427105 - 10
A novel 8-octapeptide repeat insertion in PRNP causing Huntington disease-like 1 in a Chinese family: a case report and literature review.
Ni J, Zheng F, Yu L, et al.
Journal of medical genetics 2025; (62(10)):647-652 doi:10.1136/jmg-2024-110520.
PMID: 40461170 - 11
Neuroacanthocytosis Syndromes in an Italian Cohort: Clinical Spectrum, High Genetic Variability and Muscle Involvement.
Vaisfeld A, Bruno G, Petracca M, et al.
Genes 2021; (12(3)) doi:10.3390/genes12030344.
PMID: 33652783 - 12
Identification of two compound heterozygous VPS13A large deletions in chorea-acanthocytosis only by protein and quantitative DNA analysis.
Spieler D, Velayos-Baeza A, Mühlbäck A, et al.
Molecular genetics & genomic medicine 2020; (8(9)):e1179 doi:10.1002/mgg3.1179.
PMID: 32056394 - 13
RNA toxicity in non-coding repeat expansion disorders.
Swinnen B, Robberecht W, Van Den Bosch L
The EMBO journal 2020; (39(1)):e101112 doi:10.15252/embj.2018101112.
PMID: 31721251
This page provides educational information about the genetics of Huntington Disease-Like syndromes. Always consult a genetic counselor or neurologist regarding diagnostic testing and family inheritance risks.
Get notified when new evidence is published on Huntington disease-like syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.